CA2386527A1 - Crystal form i of clarithromycin - Google Patents

Crystal form i of clarithromycin Download PDF

Info

Publication number
CA2386527A1
CA2386527A1 CA002386527A CA2386527A CA2386527A1 CA 2386527 A1 CA2386527 A1 CA 2386527A1 CA 002386527 A CA002386527 A CA 002386527A CA 2386527 A CA2386527 A CA 2386527A CA 2386527 A1 CA2386527 A1 CA 2386527A1
Authority
CA
Canada
Prior art keywords
crystal form
clarithromycin
methylerythromycin
antiobiotic
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002386527A
Other languages
French (fr)
Other versions
CA2386527C (en
Inventor
Jih-Hua Liu
David A. Riley
Stephen G. Spanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25680727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2386527(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/681,723 external-priority patent/US5858986A/en
Application filed by Individual filed Critical Individual
Publication of CA2386527A1 publication Critical patent/CA2386527A1/en
Application granted granted Critical
Publication of CA2386527C publication Critical patent/CA2386527C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention concerns the novel antiobiotic 6-O-methylerythromycin A crystal Form I, a process for its preparation, pharmaceutical compositions comprising this compound and a method of use as a therapeutic agent.
CA002386527A 1996-07-29 1997-07-25 Crystal form i of clarithromycin Expired - Lifetime CA2386527C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/681,723 1996-07-29
US08/681,723 US5858986A (en) 1996-07-29 1996-07-29 Crystal form I of clarithromycin
CA002258606A CA2258606C (en) 1996-07-29 1997-07-25 Crystal form ii of clarithromycin

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002258606A Division CA2258606C (en) 1996-07-29 1997-07-25 Crystal form ii of clarithromycin

Publications (2)

Publication Number Publication Date
CA2386527A1 true CA2386527A1 (en) 1998-02-05
CA2386527C CA2386527C (en) 2003-05-27

Family

ID=25680727

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002386527A Expired - Lifetime CA2386527C (en) 1996-07-29 1997-07-25 Crystal form i of clarithromycin
CA002419729A Expired - Lifetime CA2419729C (en) 1996-07-29 1997-07-25 Crystal form ii of clarithromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002419729A Expired - Lifetime CA2419729C (en) 1996-07-29 1997-07-25 Crystal form ii of clarithromycin

Country Status (1)

Country Link
CA (2) CA2386527C (en)

Also Published As

Publication number Publication date
CA2386527C (en) 2003-05-27
CA2419729A1 (en) 1998-02-05
CA2419729C (en) 2005-02-01

Similar Documents

Publication Publication Date Title
CA2258606A1 (en) Crystal form ii of clarithromycin
CA2387356A1 (en) Crystal form 0 and form i of clarithromycin and uses thereof
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
CA2154424A1 (en) 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
EP0811595A4 (en) Hydrochalcone derivatives, comestic compositions containing the same, and processes for the preparation of both
ZA964624B (en) Process for the preparation of microcapsule compositions.
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
WO2001029055A3 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
CA2263846A1 (en) Novel pyranoside derivatives
HUP9702480A3 (en) New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same
AU6058496A (en) New aminophenylphosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them
AU5525199A (en) N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
HUP9702479A3 (en) New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same
AU3034595A (en) New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them
CA2386527A1 (en) Crystal form i of clarithromycin
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170725

MKEX Expiry

Effective date: 20170725